Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation

New formula combines amino acids, HMB, creatine and resveratrol as Twinlab brands await proposed acquisition by cbdMD

CHARLOTTE, N.C., Sept. 24, 2026 /PRNewswire/ -- Reserveage, part of the Twinlab family of brands, announces the launch of Longev+, a new supplement available exclusively at The Vitamin Shoppe that brings muscle health and everyday performance into the healthy aging routine.* Offered in Mixed Berry stick packs, Longev+ combines essential amino acids, HMB, creatine and resveratrol to support adults seeking to stay strong, active and engaged through every stage of life.*

The launch builds on Reserveage's established presence in resveratrol and healthy aging, extending the brand into the connection between cellular wellness and physical capability.* By bringing these ingredients together in a portable format, Longev+ offers a practical addition to an active lifestyle.

"Healthy aging is personal. It means having the strength to keep doing the things you love," said Anthony Zolezzi, CEO of Twinlab. "Longev+ gives Reserveage a compelling way to connect with that consumer, bringing its healthy aging heritage into a routine centered on strength, activity and everyday vitality."

Longev+ combines four complementary ingredient categories: essential amino acids provide building blocks for muscle protein synthesis; HMB supports muscle preservation and recovery; creatine supports cellular energy production and exercise performance; and resveratrol provides antioxidant support.* Together, they connect familiar sports nutrition ingredients with Reserveage's longstanding focus on healthy aging.

The introduction aligns with consumer priorities highlighted in The Vitamin Shoppe's 2026 Health & Wellness Trend Report, including simpler wellness routines and flavorful supplement experiences. For consumers balancing exercise, work, travel and family life, Longev+ translates those priorities into an accessible format built around everyday use.

Reserveage is among the Twinlab brands included in cbdMD, Inc.'s (NYSE American: YCBD) previously announced definitive asset purchase agreement. The proposed acquisition remains subject to court approval and customary closing conditions.

"Reserveage's combination of brand heritage, product innovation and established retail relationships illustrates what attracts us to the Twinlab portfolio," said Ronan Kennedy, Chief Executive Officer of cbdMD. "Our proposed acquisition is intended to pair those strengths with the marketing capabilities and operating infrastructure we have built to support a broader consumer wellness business."

Longev+ is available in a 20-count Mixed Berry stick-pack format through The Vitamin Shoppe. Visit vitaminshoppe.com for product details and availability.

About cbdMD, Inc.

cbdMD, Inc. is a consumer wellness company focused on building a multi-brand platform across CBD, hemp-derived wellness, pet wellness, botanical wellness, supplements, longevity, functional wellness, and related consumer health categories. The Company's portfolio includes cbdMD, Paw CBD, Oasis, Bluebird Botanicals. The Company is focused on quality, transparency, compliance, consumer trust, product innovation, ecommerce, wholesale, retail support, and the development of a broader wellness platform serving multiple consumer needs. For more information, visit www.cbdmd.com.

About Twinlab

Founded in 1968, Twinlab is a heritage leader in nutritional supplements and sports nutrition, with a decades-long reputation for quality and innovation across vitamins, minerals, amino acids, and performance nutrition. The Twinlab family of brands includes Reserveage, a premium longevity and beauty-from-within brand known for its resveratrol, collagen, and healthy-aging products; Metabolife, a recognized name in weight management and Rip Fuel for performance Sports. Together, these brands have built lasting consumer trust and broad distribution across retail, wholesale, and ecommerce channels.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include, but are not limited to, statements regarding the proposed acquisition, expected revenues, revenue increases, the ability to obtain court approval and complete the transaction, integration plans, brand portfolio development, product availability, and ecommerce. These statements are based on management's current expectations, estimates, and projections and are subject to significant risks and uncertainties that could cause actual results to differ materially from those anticipated. Such risks include, but are not limited to, court approval of the ABC and complete the transaction on the anticipated terms or timeline, satisfy closing conditions, successfully integrate acquired assets and brands, retain key employees and business relationships, maintain wholesale and retail relationships, execute ecommerce and marketplace strategies, develop new product categories, achieve anticipated operational efficiencies and cost savings, manage costs and capital requirements, maintain regulatory compliance across all product categories, access capital on favorable terms, the risk that the unaudited financial information regarding the acquired brands is inaccurate or that audited financial statements meeting the requirements of Regulation S-X cannot be timely obtained, and other risks described in the Company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

Contacts

Investors:
cbdMD, Inc.
Ronan Kennedy
Chief Executive Officer and Chief Financial Officer
[email protected]
(704) 445-3064

SOURCE cbdMD, Inc.